comparemela.com

Latest Breaking News On - Payal parikh - Page 3 : comparemela.com

First Case of COVID-19 Triggering Recurrent Clots in Arm

First Case of COVID-19 Triggering Recurrent Clots in Arm By Robert Preidt HealthDay Reporter WEDNESDAY, May 19, 2021 (HealthDay News) Researchers have reported the first case of COVID-19 causing dangerous, recurring blood clots in a patient s arm. The report offers new insight into how the damage of inflammation caused by COVID-19 can linger and how best to treat recurring clots, the Rutgers University researchers said. There have been reports of lower extremity blood clots in patients after COVID-19, but this is the first known case in which COVID-19 triggered a blood clot recurrence in the upper arm. The patient was an active 85-year-old man who had a prior diagnosis of upper extremity blood clots, according to the study published online recently in the journal

First case of deep vein thrombosis (DVT) due to COVID-19

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection caused by coronavirus disease (COVID-19) induces hyperinflammatory and hypercoagulable states, leading to arterial and venous thromboembolic events. These conditions may cause severe complications and can be potentially fatal. Now, researchers at Rutgers Robert Wood Johnson Medical School report the first case of COVID-19 triggering a rare occurrence of potentially severe blood clots forming in the arms. The case report, published in the journal Viruses, sheds light on how hyperinflammatory states during COVID-19 can lead to upper extremity blood clots, called deep vein thrombosis (DVT). Deep Vein Thrombosis. Image Credit: Victor Josan/Shuttertso

COVID symptoms: Blood clots could be another complication

View Comments In the first reported case of its kind, a healthy 85-year-old man developed a rare recurrence of deep-vein blood clots in his upper arm as the result of coronavirus infection, Rutgers researchers report.  The unusual case highlights yet another way the virus that causes COVID-19 can affect people. Beyond the more common respiratory symptoms and loss of taste and smell, the virus can trigger coagulation disorders, especially clots. “This is of concern, since in 30% of these patients, the blood clot can travel to the lung and be possibly fatal,” said Dr. Payal Parikh, an assistant professor of medicine at Rutgers Robert Wood Johnson Medical School, who led the study along with Martin Blaser, director of the Center for Advanced Biotechnology and Medicine. “Other disabling complications include persistent swelling, pain and arm fatigue.”  

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.